Cellectis (CLLS) Institutional Ownership $3.50 -0.02 (-0.57%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$3.50 0.00 (0.00%) As of 05/22/2026 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Cellectis (NASDAQ:CLLS)CurrentInstitutional OwnershipPercentage63.90%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$17.17MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$1.72M Get CLLS Insider Trade Alerts Want to know when executives and insiders are buying or selling Cellectis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data CLLS Institutional Buying and Selling by Quarter Cellectis Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2026 Lido Advisors LLC10,094$32K0.0%N/A0.010% 2/13/2026 Marshall Wace LLP178,473$864K0.0%+1,610.3%0.000% 2/13/2026 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC3,178,620$15.39M0.0%N/A0.000% 2/6/2026Global Retirement Partners LLC7,038$34K0.0%N/A0.000% 11/20/2025 First Affirmative Financial Network10,149$29K0.0%-48.7%0.018% 11/17/2025 Long Focus Capital Management LLC4,123,262$11.75M0.4%-12.6%7.419% 11/17/2025 Millennium Management LLC57,740$165K0.0%+61.9%0.104% 11/17/2025 Citadel Advisors LLC221,959$633K0.0%N/A0.399% 11/14/2025 Virtu Financial LLC25,211$72K0.0%N/A0.045% 11/14/2025 B Group Inc.3,281,501$9.35M7.1%+0.8%5.904% Get the Latest News and Ratings for CLLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cellectis and its competitors with MarketBeat's FREE daily newsletter. 11/10/2025 Delaney Dennis R24,000$68K0.0%N/A0.043% 5/21/2025Acadian Asset Management LLC46,377$55K0.0%+132.9%0.083% 5/19/2025UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC4,722,664$5.86M0.0%+228.4%8.496% 5/15/2025Long Focus Capital Management LLC4,717,293$5.85M0.2%+2.2%8.487% 5/15/2025OLD Mission Capital LLC25,289$31K0.0%N/A0.045% 5/7/2025Baillie Gifford & Co.139,047$172K0.0%-52.1%0.250% 2/17/2025Millennium Management LLC534,551$962K0.0%N/A0.962% 2/14/2025B Group Inc.3,081,501$5.55M3.4%N/A5.544% 2/13/2025Wells Fargo & Company MN24,590$44K0.0%+103.4%0.044% 2/11/2025LPL Financial LLC85,272$153K0.0%-7.7%0.153% 1/31/2025Baillie Gifford & Co.290,429$523K0.0%-58.1%0.523% 12/19/2024Principal Financial Group Inc.411,800$881K0.0%-5.8%0.741% 11/5/2024Baillie Gifford & Co.693,939$1.49M0.0%-1.9%1.249% 10/31/2024Principal Financial Group Inc.411,800$881K0.0%-5.8%0.741% 10/10/2024First Affirmative Financial Network21,094$45K0.0%N/A0.038% 8/15/2024Long Focus Capital Management LLC4,617,293$8.63M0.3%+2.9%8.307% 8/12/2024XTX Topco Ltd15,320$29K0.0%N/A0.028% 7/29/2024Principal Financial Group Inc.437,000$817K0.0%+2.9%0.786% 7/25/2024Baillie Gifford & Co.707,630$1.32M0.0%-14.5%1.273% 5/1/2024Baillie Gifford & Co.827,248$2.19M0.0%+1.3%1.488% 4/29/2024Principal Financial Group Inc.424,533$1.13M0.0%+6.2%0.764% 2/7/2024Principal Financial Group Inc.399,627$1.23M0.0%-39.1%0.719% 1/26/2024Baillie Gifford & Co.816,643$2.52M0.0%-29.8%1.469% 11/13/2023Baillie Gifford & Co.1,164,009$1.84M0.0%-18.0%2.094% 11/2/2023Principal Financial Group Inc.656,600$1.04M0.0%-1.6%1.181% 8/7/2023Principal Financial Group Inc.667,041$1.31M0.0%-51.0%1.200% 7/28/2023Baillie Gifford & Co.1,418,996$2.80M0.0%-13.5%2.553% 5/17/2023Long Focus Capital Management LLC4,487,293$8.66M0.5%+67.2%8.074% 5/15/2023Bpifrance SA2,186,960$4.22M0.1%N/A3.935% 5/12/2023Long Focus Capital Management LLC2,415,996$4.66M0.5%-10.0%4.347% Your $29.97 book is free today (Ad)Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.Normally $29.97. Today it's free. Grab your copy now.5/10/2023Oppenheimer & Co. Inc.116,163$224K0.0%+54.8%0.209% 5/9/2023Principal Financial Group Inc.1,361,860$2.63M0.0%+2.1%2.450% 5/3/2023Baillie Gifford & Co.1,639,896$3.17M0.0%+173.4%2.951% 4/12/2023Vontobel Holding Ltd.30,000$58K0.0%+114.3%0.054% 3/6/2023OLD Mission Capital LLC11,752$25K0.0%N/A0.021% 2/9/2023Principal Financial Group Inc.1,334,050$2.80M0.0%-0.7%2.920% 2/8/2023Oppenheimer & Co. Inc.75,052$158K0.0%-18.4%0.164% 11/15/2022Long Focus Capital Management LLC2,683,633$6.15M0.6%-3.9%5.889% 11/14/2022Oppenheimer & Co. Inc.91,963$211K0.0%+21.6%0.202% 10/27/2022Baillie Gifford & Co.788,837$1.81M0.0%-10.5%1.731% 9/23/2022Capital Wealth Alliance LLC13,509$680K0.3%N/A0.030% 8/10/2022Principal Financial Group Inc.1,348,312$3.82M0.0%+11.0%2.963% 8/8/2022Baillie Gifford & Co.880,932$2.49M0.0%-18.6%1.936% 8/2/2022Capital Wealth Alliance LLC13,509$680K0.4%N/A0.030% 7/26/2022Mirae Asset Global Investments Co. Ltd.186,018$526K0.0%+30.7%0.409% 5/12/2022Oppenheimer & Co. Inc.74,654$339K0.0%N/A0.164% 5/11/2022Princeton Capital Management LLC10,929$50K0.0%N/A0.024% 5/10/2022Mirae Asset Global Investments Co. Ltd.142,341$646K0.0%-15.8%0.313% 5/9/2022Principal Financial Group Inc.1,214,725$5.52M0.0%-0.9%2.670% 2/15/2022Capital International Investors1,592,054$12.93M0.0%+18.9%3.500% 2/15/2022683 Capital Management LLC352,638$2.86M0.1%+488.7%0.775% 2/14/2022Long Focus Capital Management LLC1,156,346$9.39M1.2%N/A2.542% 2/14/2022Credit Suisse AG1,203,301$9.77M0.0%+0.3%2.646% 2/9/2022Principal Financial Group Inc.1,225,553$9.95M0.0%-1.3%2.694% 2/4/2022Envestnet Asset Management Inc.17,196$140K0.0%N/A0.038% 2/3/2022Advisor Group Holdings Inc.4,950$40K0.0%+73.9%0.011% CLLS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CLLS shares? During the previous two years, 18 institutional investors and hedge funds held shares of Cellectis. The most heavily invested institutionals were UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ($15.39M), Long Focus Capital Management LLC ($11.75M), B Group Inc. ($9.35M), Principal Financial Group Inc. ($881K), Marshall Wace LLP ($864K), Citadel Advisors LLC ($633K), and Baillie Gifford & Co. ($172K).Learn more on Cellectis' institutional investors. What percentage of Cellectis' stock is owned by institutional investors? 63.90% of Cellectis' stock is owned by institutional investors. Learn more on CLLS's institutional investor holdings. Which institutional investors have been buying Cellectis' stock? Of the 16 institutional investors that purchased Cellectis' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC ($6.46M), B Group Inc. ($3.11M), Millennium Management LLC ($556.63K), Long Focus Capital Management LLC ($230K), Citadel Advisors LLC ($221.96K), Marshall Wace LLP ($168.04K), and Acadian Asset Management LLC ($26.46K). How much institutional buying is happening at Cellectis? Institutional investors have bought a total of 3,682,040 shares in the last 24 months. This purchase volume represents approximately $17.17M in transactions. Which of Cellectis' major shareholders have been selling company stock? The following institutional investors have sold Cellectis stock in the last 24 months: Long Focus Capital Management LLC ($594.03K), and First Affirmative Financial Network ($9.64K). How much institutional selling is happening at Cellectis? Institutional investors have sold a total of 603,667 shares in the last 24 months. This volume of shares sold represents approximately $1.72M in transactions. Related Companies RXRX Major Shareholders VIR Major Shareholders GHRS Major Shareholders ATAI Major Shareholders PGEN Major Shareholders NUVB Major Shareholders MBX Major Shareholders IMCR Major Shareholders KALV Major Shareholders AMLX Major Shareholders This page (NASDAQ:CLLS) was last updated on 5/23/2026 by MarketBeat.com Staff. From Our PartnersI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellectis S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellectis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
